A Pathway to Coverage of GLP-1s in Medicare and Medicaid
Last fall, the Trump administration announced an historic expansion of obesity treatment coverage for Medicare and Medicaid beneficiaries.
Letters from the Director Archive
Weight Regain After Obesity Treatment
As options for the treatment of obesity have rapidly expanded, a major concern has been weight regain among treated patients with obesity.
Obesity Care Week (OCW) brings together advocates and organizations nationwide to raise awareness, educate, and advocate for people affected by obesity.
The New Dietary Guidelines for Americans, 2025-2030
Earlier this month, the US Department of Health and Human Services (HHS) and the US Department of Agriculture (USDA) released the 2025-2030 Dietary Guidelines for Americans (DGAs).
Guest Letter: A Path Forward: What’s Possible for Obesity Care in 2026
Last month, the administration delivered another critical victory: a landmark Medicare and Medicaid price negotiation deal for the GLP-1 medications Wegovy and Zepbound.
Inclusive and supportive workplaces for people with obesity remain the exception rather than the norm.
The Changing Global Obesity Landscape
The global burden of obesity continues to rise. Without effective and collective action, overweight and obesity will continue to increase globally.
The Relationship between Obesity and the Immune System
This month STOP is exploring a topic that is relatively new to us, the relationship obesity has with immune health.
The Role of Physical Activity in Obesity Treatment
Research has been clear that physical activity should be integrated into both the prevention and comprehensive treatments for obesity.
Roadmap for Transforming Obesity Disease Management
Last month, the Center for Biomedical System Design (CBSD) program at Tufts Medical Center's Institute for Clinical Research and Health Policy Studies published a comprehensive roadmap for transforming obesity disease management in the United States.